US Patent Issued to SHANGHAI HENLIUS BIOTECH on Sept. 16 for "Anti-tigit antibodies, multispecific antibodies comprising the same, and methods of using the same" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,858, issued on Sept. 16, was assigned to SHANGHAI HENLIUS BIOTECH INC. (Shanghai).

"Anti-tigit antibodies, multispecific antibodies comprising the same, and methods of using the same" was invented by Ming Yang (Shanghai), Wenfeng Xu (Shanghai), Wei-Dong Jiang (Shanghai) and Jie Xue (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are anti-TIGIT antibodies that bind to "T cell immunoreceptor with Ig and ITIM domains (TIGIT)", including multispecific anti-TIGIT antibodies with binding specificity for TIGIT and one or more additional antigen, and methods of using the same. In certain embodiments, the anti-TIGIT antibodies comprises a ...